Cipher Pharmaceuticals Inc.
CPHRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $12,833 | $13,381 | $12,019 | $11,822 |
| % Growth | -4.1% | 11.3% | 1.7% | – |
| Cost of Goods Sold | $2,348 | $2,498 | $2,879 | $5,129 |
| Gross Profit | $10,485 | $10,883 | $9,140 | $6,693 |
| % Margin | 81.7% | 81.3% | 76% | 56.6% |
| R&D Expenses | $0 | $0 | $21 | $0 |
| G&A Expenses | $3,143 | $4,085 | $4,011 | $4,036 |
| SG&A Expenses | $3,714 | $4,085 | $4,823 | $4,848 |
| Sales & Mktg Exp. | $571 | $0 | $812 | $812 |
| Other Operating Expenses | $1,797 | $1,807 | $1,822 | $1,511 |
| Operating Expenses | $5,511 | $5,892 | $6,666 | $6,359 |
| Operating Income | $4,974 | $4,991 | $2,474 | $1,845 |
| % Margin | 38.8% | 37.3% | 20.6% | 15.6% |
| Other Income/Exp. Net | -$716 | $1,414 | -$587 | -$4,699 |
| Pre-Tax Income | $4,258 | $6,405 | $1,887 | -$2,854 |
| Tax Expense | -$1,243 | $512 | -$737 | -$6,198 |
| Net Income | $5,501 | $5,893 | $2,624 | $3,344 |
| % Margin | 42.9% | 44% | 21.8% | 28.3% |
| EPS | 0.21 | 0.23 | 0.1 | 0.13 |
| % Growth | -8.7% | 130% | -23.1% | – |
| EPS Diluted | 0.21 | 0.22 | 0.1 | 0.13 |
| Weighted Avg Shares Out | 25,375 | 25,869 | 25,612 | 25,723 |
| Weighted Avg Shares Out Dil | 25,948 | 26,507 | 26,202 | 25,723 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $238 | $351 | $469 | $529 |
| Depreciation & Amortization | $1,797 | $1,807 | $1,822 | $1,337 |
| EBITDA | $6,771 | $6,798 | $4,296 | $1,671 |
| % Margin | 52.8% | 50.8% | 35.7% | 14.1% |